Correspondence (letter to the editor): Treatment Option not Mentioned

af Ezziddin, Samer, Biersack, Hans-Jürgen
Udgivet 2013

Correspondence (letter to the editor): Radioembolization as a Treatment Option

af Ezziddin, Samer, Bücker, Arno, Lammert, Frank
Udgivet i Dtsch Arztebl Int (2015)

Diagnosis of extra-adrenal phaeochromocytoma after nephrectomy

af Barski, Dimitri, Ezziddin, Samer, Heikaus, Sebastian, Neumann, Hartmut P.H.
Udgivet 2014

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

af Biersack Hans-Jürgen, Wilinek Winfried, Herrlinger Ulrich, Ahmadzadehfar Hojjat, Sabet Amir, Ezziddin Samer
Udgivet 2011-08-01

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

af Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Udgivet 2011

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG

af Ezziddin, Samer, Sabet, Amir, Ko, Yon-Dschun, Xun, Sunny, Matthies, Alexander, Biersack, Hans-Jürgen
Udgivet 2012

May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

af Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Udgivet 2013

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

af Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Udgivet 2013

Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(17...

af Rosar, Florian, Hau, Fabian, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Udgivet i Theranostics (2021)

Renal Safety of [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

af Rosar, Florian, Kochems, Niklas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Khreish, Fadi, Ezziddin, Samer
Udgivet i Cancers (Basel) (2021)

Determination of split renal function by PSMA imaging: comparison of (68)Ga-PSMA-11 PET with (99m)Tc-MAG3 scintigraphy

af Rosar, Florian, Pauly, Peter, Ries, Martin, Schaefer-Schuler, Andrea, Maus, Stephan, Schreckenberger, Mathias, Khreish, Fadi, Ezziddin, Samer
Udgivet i Am J Nucl Med Mol Imaging (2020)

Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

af Rosar, Florian, Ribbat, Kalle, Ries, Martin, Linxweiler, Johannes, Bartholomä, Mark, Maus, Stephan, Schreckenberger, Mathias, Ezziddin, Samer, Khreish, Fadi
Udgivet i EJNMMI Res (2020)

Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of (64)Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates

af Martin, Sebastian, Maus, Stephan, Stemler, Tobias, Rosar, Florian, Khreish, Fadi, Holland, Jason P., Ezziddin, Samer, Bartholomä, Mark D.
Udgivet i Mol Imaging Biol (2020)

Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

af Rosar, Florian, Krause, Jonas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Udgivet i Pharmaceutics (2021)

Efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

af Sabet, Amir, Haug, Alexander R, Eiden, Collin, Auernhammer, Christoph J, Simon, Birgit, Bartenstein, Peter, Biersack, Hans J, Ezziddin, Samer
Udgivet i Am J Nucl Med Mol Imaging (2017)

Comparison of different methods for post-therapeutic dosimetry in [(177)Lu]Lu-PSMA-617 radioligand therapy

af Rosar, Florian, Schön, Niklas, Bohnenberger, Hendrik, Bartholomä, Mark, Stemler, Tobias, Maus, Stephan, Khreish, Fadi, Ezziddin, Samer, Schaefer-Schuler, Andrea
Udgivet i EJNMMI Phys (2021)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

af Handkiewicz-Junak, Daria, Poeppel, Thorsten D., Bodei, Lisa, Aktolun, Cumali, Ezziddin, Samer, Giammarile, Francesco, Delgado-Bolton, Roberto C., Gabriel, Michael
Udgivet i Eur J Nucl Med Mol Imaging (2018)

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

af Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Udgivet 2013

The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer

af Fleckenstein, Jochen, Jelden, Michael, Kremp, Stephanie, Jagoda, Philippe, Stroeder, Jonas, Khreish, Fadi, Ezziddin, Samer, Buecker, Arno, Rübe, Christian, Schneider, Guenther K.
Udgivet i PLoS One (2016)

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and s...

af Dizdarevic, Sabina, Petersen, Peter Meidahl, Essler, Markus, Versari, Annibale, Bourre, Jean-Cyril, la Fougère, Christian, Valdagni, Riccardo, Paganelli, Giovanni, Ezziddin, Samer, Kalinovský, Ján, Bayh, Inga, Du, Yong
Udgivet i Eur J Nucl Med Mol Imaging (2019)